Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients

Orit Freedman, Eitan Amir, George Dranitsaris, Julie Napolskikh, Ritu Kumar, Michael Fralick, Stephen Chia, Teresa Petrella, Susan Dent, Katia Tonkin, Imran Ahmad, Daniel Rayson, Mark Clemons

科研成果: 期刊稿件 › 文章 › 同行评审

8 引用 （Scopus）

指纹

探究 'Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients' 的科研主题。它们共同构成独一无二的指纹。

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Neuroscience

Agricultural and Biological Sciences

Medicine and Dentistry

Keyphrases